| # | Drug | Count |
|---|---|---|
| 0 | LETROZOLE | 299 |
| 1 | LETROZOLE TABLETS | 253 |
| 2 | FULVESTRANT | 241 |
| 3 | RIBOCICLIB | 231 |
| 4 | PALBOCICLIB | 176 |
| 5 | DENOSUMAB | 135 |
| 6 | ZOLEDRONIC ACID | 101 |
| 7 | ANASTROZOLE | 95 |
| 8 | CAPECITABINE | 92 |
| 9 | ANASTROZOLE TABLETS | 76 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RIBOCICLIB | 231 | 0.0080 |
| 1 | FULVESTRANT | 241 | 0.0076 |
| 2 | CARBACHOL | 1 | 0.0072 |
| 3 | LETROZOLE TABLETS | 253 | 0.0055 |
| 4 | LETROZOLE | 299 | 0.0051 |
| 5 | IBANDRONATE SODIUM | 13 | 0.0044 |
| 6 | GOSERELIN | 52 | 0.0040 |
| 7 | ANASTROZOLE TABLETS | 76 | 0.0038 |
| 8 | EXEMESTANE | 72 | 0.0035 |
| 9 | VINORELBINE | 22 | 0.0033 |
| # | Drug class | Count |
|---|---|---|
| 0 | Aromatase Inhibitor [EPC] | 402 |
| 1 | Estrogen Receptor Antagonist [EPC] | 252 |
| 2 | Kinase Inhibitor [EPC] | 252 |
| 3 | RANK Ligand Inhibitor [EPC] | 135 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 112 |
| 5 | Microtubule Inhibitor [EPC] | 68 |
| 6 | mTOR Inhibitor Immunosuppressant [EPC] | 65 |
| 7 | Alkylating Drug [EPC] | 53 |
| 8 | Calcium [EPC] | 39 |
| 9 | Provitamin D2 Compound [EPC] | 38 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Estrogen Receptor Antagonist [EPC] | 252 | 0.0065 |
| 1 | Aromatase Inhibitor [EPC] | 402 | 0.0037 |
| 2 | RANK Ligand Inhibitor [EPC] | 135 | 0.0007 |
| 3 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 10 | 0.0005 |
| 4 | HER2/neu Receptor Antagonist [EPC] | 37 | 0.0005 |
| 5 | Microtubule Inhibitor [EPC] | 68 | 0.0005 |
| 6 | Kinase Inhibitor [EPC] | 252 | 0.0005 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 112 | 0.0004 |
| 8 | Calcium [EPC] | 39 | 0.0003 |
| 9 | Photoenhancer [EPC] | 1 | 0.0003 |